New evidence may settle prostate cancer focal therapy debate
Urologic oncologists remain split on whether focal therapy for localized prostate cancer matches the outcomes of surgery or radiation. Upcoming data could clarify its effectiveness and safety profile.
Related stories
This summary is AI-generated and original to Mobble; the linked article is the authoritative source.
Original headline: “Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?.” Browse more stories.